GleamWall
中文EN

CODX Co-Diagnostics, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1692415 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY69.1%
TTM net income YoY-47.5%
TTM EPS YoY60.1%
Revenue 3-yr CAGR-43.1%
Net income 3-yr CAGR—

Margins

Gross margin20.3%
Operating margin-5,614.3%
Net margin-5,527.6%
FCF margin-3,165.7%
EBITDA margin-5,504.0%

Returns

ROE-194.5%
ROA-165.0%
ROIC (approx.)-207.8%
Asset turnover0.03x

Leverage & solvency

Liabilities / assets26.3%
Debt / equity0.00x
Current ratio0.77x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.57x
Accruals ratio-71.6%
Payout ratio—
Capex / revenue35.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$622,489$3.92M
Cost of revenue$222,377$999,124
Gross profit$400,112$2.92M
R&D expense$19.14M$20.98M
SG&A expense$9.06M$16.16M
Operating income-$50.17M-$40.08M
Pretax income-$48.51M-$37.58M
Income tax-$1.62M$57,368
Net income-$46.90M-$37.64M
EBITDA-$49.06M-$38.70M
EPS (basic)-35.25-37.22
EPS (diluted)-35.25-37.22
Weighted avg. shares (diluted)1.33M1.01M
Balance sheet
Cash & equivalents$11.88M$2.94M
Short-term investments—$26.81M
Receivables$190,375$132,570
Inventory$992,397$1.07M
Current assets$13.69M$32.29M
PP&E, net$2.27M$2.76M
Intangibles$7.22M$26.10M
Total assets$24.74M$63.56M
Current liabilities$3.54M$7.32M
Total liabilities$4.11M$9.69M
Shareholders' equity$20.63M$53.88M
Shares outstanding2.10M1.10M
Cash flow statement
Operating cash flow-$29.14M-$29.16M
Capital expenditure$700,047$748,352
Free cash flow-$29.84M-$29.90M
Investing cash flow$26.27M$17.07M
Financing cash flow$11.81M$103,914
Depreciation & amortization$1.11M$1.38M
Stock-based compensation$2.25M$5.43M

Free plan shows the latest 2 periods; Pro shows all 10 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.